Lifecore Biomedical Inc. (LFCR)
6.41
0.05 (0.79%)
At close: Jan 14, 2025, 3:59 PM
6.43
0.31%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 5.67 |
| Market Cap | 237.33M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -11.45 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 6.8 |
| Volume | 306,802 |
| Avg. Volume (20D) | 247,714 |
| Open | 6.28 |
| Previous Close | 6.36 |
| Day's Range | 6.14 - 6.48 |
| 52-Week Range | 3.68 - 8.90 |
| Beta | undefined |
About LFCR
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a ...
Sector Healthcare
IPO Date Feb 15, 1996
Employees 524
Stock Exchange NASDAQ
Ticker Symbol LFCR
Website https://www.lifecore.com
Analyst Forecast
According to 3 analyst ratings, the average rating for LFCR stock is "Hold." The 12-month stock price forecast is $8, which is an increase of 24.80% from the latest price.
Buy 33.33%
Hold 66.67%
Sell 0.00%
3 months ago ·
Source
+14.23%
Lifecore Biomedical shares are trading higher afte...
Unlock content with
Pro Subscription
4 months ago ·
Source
-16.24%
Lifecore Biomedical shares are trading lower after Barrington Research downgraded the stock from Outperform to Market Perform.
